Badalona Major Depressive Disorder Database Study
Therapeutic Strategies for the Management of Patients With Major Depressive Disorder (MDD) and Suboptimal Response to Antidepressant Drugs in Primary Care: the Badalona Database Study
1 other identifier
observational
2,260
1 country
1
Brief Summary
A retrospective study using a data base of anonymized medical records. The purpose of the study is to examine the different therapeutic strategies for the management of patients with major depressive disorder (MDD) and suboptimal response to antidepressant drugs in primary care
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2011
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 28, 2011
CompletedFirst Posted
Study publicly available on registry
October 5, 2011
CompletedStudy Start
First participant enrolled
November 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2012
CompletedJanuary 12, 2012
January 1, 2012
September 28, 2011
January 11, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Description of the antidepressant strategies switches
Number and type of treatment changes including combination, switch, or augmentation strategies.
18 months
Secondary Outcomes (5)
Health care resource utilization
18 months
Health care costs
18 months
Hamilton Depression Rating Scale
18 months
Medication possession rate to evaluate adherence
18 months
Referral to psychiatrist office
18 months
Study Arms (2)
Patients with suboptimal response
Patients with symptomatic remission
Eligibility Criteria
Primary care clinic
You may qualify if:
- An International Classification of Primary Care (ICPC-2) or DSM-IV-TR diagnosis for major depressive disorder (MDD)
- At least 8 weeks of antidepressant treatment during the identification period of 01 January 2008 - 31 December 2009
- months of enrollment with medical and pharmacy records after index episode date
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (1)
Research Site
Badalona, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 28, 2011
First Posted
October 5, 2011
Study Start
November 1, 2011
Study Completion
January 1, 2012
Last Updated
January 12, 2012
Record last verified: 2012-01